COVID-19 Vaccine: Reliance pledges support for nationwide distribution and supply chain

In the nation’s fight against the coronavirus pandemic, the multinational conglomerate Reliance Industries is preparing and has assured to do its bit when the COVID-19 vaccine will be available for the masses.

Nita Ambani, Chairperson and Founder of Reliance Foundation, while speaking at the 43rd annual general meeting yesterday, announced that the company will voluntarily step forward for the digital distribution and supply chain of the COVID-19 vaccine, once it is made available for masses.

Further, she added, Reliance will ensure that vaccines will reach each and every part of the country.

Meanwhile, Microsoft co-founder and philanthropist Bill Gates believe that India’s pharmaceutical industry will be able to produce COVID-19 vaccine not just for the country but also for the entire world.

Apart from speaking about the vaccine, Mrs Ambani also highlighted that the war against the deadly COVID-19 is a long one, and therefore the company is looking forward to partner with the government as well as local municipalities to ramp up Coronavirus testing in India.

 “The mega-scale testing for Coronavirus across the country will be done with the help of Jio’s digital infrastructure. It’s our duty, ‘dharma’ and ‘seva’ to serve the nation.”

~ Nita Ambani, Chairperson & Founder

Reliance Foundation also provided free fuel for vehicles used in the Emergency Services across the country during the outbreak.

Further, under Mission Anna Seva, Mrs Ambani underlined that the company has provided at least five crore meals to frontline workers, daily-wage earners, and marginalised communities.

The company has also produced one lakh masks and PPEs (Personal Protective Equipment) for healthcare workers and professionals in India on a daily basis.

Reliance Foundation, on the other hand, has also donated a sum of INR 535 crore to various relief funds amidst the nationwide lockdown. This also includes the company’s contribution to the PM CARES fund.

Leave a Reply

Your email address will not be published. Required fields are marked *